FDA Inspection
Strides Pharma, Inc.Strides Pharma, Inc. – FDA Inspection, Mar 16, 2017
Record Details
This FDA Inspection record concerns Strides Pharma, Inc., with an inspection on March 16, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 66cbcfc4-e122-4210-b707-70d6dbfc6d9c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1009619
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Strides Pharma, Inc.
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 23, 2025 | Not classified | New York District Office | |
| February 8, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 23, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 5, 2019 | VAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| June 4, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Strides Pharma, Inc.
- FDA Inspection 1292202 - 2025-12-23
- FDA Inspection 1162483 - 2022-02-08
- FDA Inspection 1103039 - 2019-08-23
- FDA Inspection 1092153 - 2019-06-05
- FDA Inspection 932525 - 2015-06-04
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.